Bridgefront Capital’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,000
Closed -$172K 725
2024
Q3
$172K Sell
11,000
-5,102
-32% -$79.7K 0.07% 467
2024
Q2
$276K Buy
+16,102
New +$276K 0.12% 321